Tango Therapeutics Stock (NASDAQ: TNGX) stock price, news, charts, stock research, profile.
Open | $7.540 |
Close | $7.330 |
Volume / Avg. | 447.982K / 607.974K |
Day Range | 7.180 - 7.580 |
52 Wk Range | 2.470 - 13.030 |
Market Cap | $782.245M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 16.39% |
Days to Cover | 15.18 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Tango Therapeutics (NASDAQ: TNGX) through any online brokerage.
Other companies in Tango Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB) and Zentalis Pharma (NASDAQ:ZNTL).
The latest price target for Tango Therapeutics (NASDAQ: TNGX) was reported by Cantor Fitzgerald on Thursday, April 4, 2024. The analyst firm set a price target for 0.00 expecting TNGX to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.
The stock price for Tango Therapeutics (NASDAQ: TNGX) is $7.33 last updated April 25, 2024 at 4:20 PM EDT.
There are no upcoming dividends for Tango Therapeutics.
Tango Therapeutics’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Tango Therapeutics.
Tango Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.